bis(5-amidino-2-benzimidazolyl)methane has been researched along with Chronic Disease in 1 studies
bis(5-amidino-2-benzimidazolyl)methane: aromatic diamidine which has a significant suppressive effect on the cytopathology & yield of respiratory synctial (RS) virus; RN given refers to parent cpd
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fish, PV | 1 |
| Barber, CG | 1 |
| Brown, DG | 1 |
| Butt, R | 1 |
| Collis, MG | 1 |
| Dickinson, RP | 1 |
| Henry, BT | 1 |
| Horne, VA | 1 |
| Huggins, JP | 1 |
| King, E | 1 |
| O'Gara, M | 1 |
| McCleverty, D | 1 |
| McIntosh, F | 1 |
| Phillips, C | 1 |
| Webster, R | 1 |
1 other study available for bis(5-amidino-2-benzimidazolyl)methane and Chronic Disease
| Article | Year |
|---|---|
Selective urokinase-type plasminogen activator inhibitors. 4. 1-(7-sulfonamidoisoquinolinyl)guanidines.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Binding Sites; Chronic Disease; Crystallography, X-Ray; G | 2007 |